Methenamine Hippurate Orion (Methenamine Hippurate)

After ingestion, methenamine hippurate is excreted unchanged in the urine. In an acidic environment (pH < 6), it hydrolyses to formaldehyde and ammonia. Formaldehyde acts as a broad‑spectrum bactericidal agent, denaturing microbial proteins and nucleic acids, thereby inhibiting infection in the urinary tract.

The appropriate dose of Methenamine Hippurate is determined by the prescribing clinician based on the individual’s medical condition, renal function, and urinary pH. Dosage forms and strengths may vary, and the prescriber will provide specific instructions tailored to each patient.

Safety data for Methenamine Hippurate in pregnancy and lactation are limited. It is generally advised that pregnant or breastfeeding women discuss potential risks with their healthcare provider before initiating therapy, as the benefit‑risk balance must be evaluated on a case‑by‑case basis.

To order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methenamine Hippurate differs from agents such as nitrofurantoin or trimethoprim‑sulfamethoxazole because it requires acidic urine to become active, offering a non‑antibiotic approach that reduces the risk of bacterial resistance. However, its efficacy depends on urine pH, whereas other antibiotics act independently of urinary acidity.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. No special refrigeration is required for this oral formulation.

Methenamine Hippurate Orion is taken orally, usually with a full glass of water. It should be taken with meals or as directed by the prescriber to maintain consistent urinary acidity. Patients are often advised to monitor urine pH and avoid alkaline foods or medications that could raise urinary pH.

Serious adverse events, although rare, include allergic reactions such as rash, angioedema, or anaphylaxis, as well as hematuria, hepatic dysfunction, severe metabolic acidosis, and interstitial nephritis. Any signs of these conditions require immediate medical attention.

Methenamine Hippurate is contraindicated in patients with known hypersensitivity to the drug, those with severely alkaline urine (pH > 7), and individuals with significant renal impairment where drug excretion is compromised. Caution is also advised for patients taking strong alkalinizing agents.